SCOPE 2025: Analyzing RWD for Actionable Insights in Alzheimer’s disease

To create a market assessment, more and more brand strategists are moving towards the use of RWD and RWE. In this blog, we walk through a hypothetical example – sizing the market for Hemophilia A – doing just that.  Creating a market assessment is a critical step in commercializing a new drug. This is because…

Although biologics and biosimilar drugs only represent 2% of U.S. prescription volume, these naturally sourced medications have recently become the focus of much discussion across healthcare channels. Biologics – often considered specialty drugs – have accounted for as much as 37% of drug spending in a single year.

Level up your audience segmentation Advertising is awash in data, but healthcare advertisers can struggle to separate valuable insights from noise when planning and optimizing campaigns. But how do you identify data that will actually help you build and optimize your campaigns? Watch this podcast to learn more about precise audience segmentation and gain valuable…